People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Healthtech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Superconductive Health, Inc. | — | Healthtech | Series B | $61.0M | $716.3M | 2021 |
| Transcend Inc. | — | Other | Series B | $44.5M | $280.5M | 2023 |
Bryan Offutt at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bryan Offutt on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| MICHAEL FARRELL | 1 | 6 |
| James Campbell | 1 | 5 |
| Max Gazor | 1 | 3 |
| Vas Natarajan | 1 | 2 |
| Abe Gong | 1 | 1 |
| Elizabeth Immen | 1 | 1 |
| Ben Castleton | 1 | 1 |
| Katherine Parker | 1 | 1 |
| Benjamin Brook | 1 | 1 |
| Brandon Wiebe | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.